Deep Learning Diagnostic and Risk-stratification for IPF and COPD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Deep Learning Diagnostic and Risk-stratification for IPF and COPD — Stella

Home/Lung; Disease, Interstitial, With Fibrosis/

View on ClinicalTrials.gov

Recruiting

Back to Lung; Disease, Interstitial, With Fibrosis trials

Trial locations(1 site)

Switzerland

Centre Hospitalier du Valais Romand, Sion, Valais

Key details

Sponsor

Pediatric Clinical Research Platform

Collaborators

University Hospital, Geneva, Swiss Federal Institute of Technology

Enrollment target

~160 participants

Started

April 2023

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.